Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
- DOI
- 10.1038/s41591-025-04186-5
- Published
- 2026 Apr
- Container
- Nature medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-025-04186-5,
title = {Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.},
author = {Duttagupta S and Messaoudene M and Hunter S and Desilets A and Jamal R and Mihalcioiu C and Belkaid W and Marcoux N and Fidelle M and Suissa D and Ponce M and Geiger M and Malo J and Piccinno G and Punčochář M and Filin A and Heidrich V and Rusu D and Mbaye B and Durand S and Ben Aissa I and Puller V and de Lahondès R and Blais N and Tehfe M and Owen S and Bélanger K and Parvathy SN and Shieh B and Raphael J and Lenehan J and Breadner D and Rothenstein J and Rozza N and Maillou J and Nili S and Prifti DK and Pinto F and Armanini F and Kim-Schulze S and Marron TU and Kroemer G and Derosa L and Zitvogel L and Silverman M and Segata N and Maleki Vareki S and Routy B and Elkrief A},
year = {2026},
journal = {Nature medicine},
doi = {10.1038/s41591-025-04186-5},
url = {https://doi.org/10.1038/s41591-025-04186-5}
}RIS
TY - JOUR TI - Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial. AU - Duttagupta S AU - Messaoudene M AU - Hunter S AU - Desilets A AU - Jamal R AU - Mihalcioiu C AU - Belkaid W AU - Marcoux N AU - Fidelle M AU - Suissa D AU - Ponce M AU - Geiger M AU - Malo J AU - Piccinno G AU - Punčochář M AU - Filin A AU - Heidrich V AU - Rusu D AU - Mbaye B AU - Durand S AU - Ben Aissa I AU - Puller V AU - de Lahondès R AU - Blais N AU - Tehfe M AU - Owen S AU - Bélanger K AU - Parvathy SN AU - Shieh B AU - Raphael J AU - Lenehan J AU - Breadner D AU - Rothenstein J AU - Rozza N AU - Maillou J AU - Nili S AU - Prifti DK AU - Pinto F AU - Armanini F AU - Kim-Schulze S AU - Marron TU AU - Kroemer G AU - Derosa L AU - Zitvogel L AU - Silverman M AU - Segata N AU - Maleki Vareki S AU - Routy B AU - Elkrief A PY - 2026 JO - Nature medicine DO - 10.1038/s41591-025-04186-5 UR - https://doi.org/10.1038/s41591-025-04186-5 ER -
APA
S, D., M, M., S, H., A, D., R, J., C, M., W, B., N, M., M, F., D, S., M, P., M, G., J, M., G, P., M, P., A, F., V, H., D, R., B, M., S, D., I, B. A., V, P., R, D. L., N, B., M, T., S, O., K, B., SN, P., B, S., J, R., J, L., D, B., J, R., N, R., J, M., S, N., DK, P., F, P., F, A., S, K., TU, M., G, K., L, D., L, Z., M, S., N, S., S, M. V., B, R., & A, E. (2026). Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.. Nature medicine. https://doi.org/10.1038/s41591-025-04186-5
Source records
- pubmed · retrieved 2026-09-25T23:54:37.391Z